Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 23Neoplasms 19Cancer Pain 9Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Pain, Postoperative 3Sarcoma 2Pleural Effusion, Malignant 2Lymphoma, Follicular 2Diverticulosis, Colonic 2Carcinoma, Hepatocellular 2Burns 2Brain Neoplasms 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1

Interventions

Hydromorphone 2NF protocol 1Meropenem 1Levofloxacin 1Ketorolac 1Heller Myotomy 1Glucose 1Fentanyl 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Emergencies × Fentanyl × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡